The Acoustic-Based Biosensors segmentation by application delineates three primary domains that collectively drive market revenue. Medical diagnostics represents the largest share, accounting for roughly 55% of total sales, as clinicians adopt label‑free, real‑time detection of biomarkers for infectious diseases, oncology, and cardiovascular conditions. The high clinical value, reimbursement pathways, and integration with point‑of‑care platforms underpin this dominance. Environmental monitoring follows with an estimated 30% contribution, reflecting growing regulatory pressure to detect pollutants, toxins, and pathogens in water and air; acoustic sensors offer low‑power operation and continuous sampling, which are critical for remote stations. Food safety comprises the remaining 15%, where manufacturers employ acoustic biosensors to identify microbial contamination and allergens during processing, leveraging rapid turnaround and minimal sample preparation. Together, these application segments define the market’s structural composition, guiding investment and R&D allocation across the acoustic biosensing ecosystem.